In addition, a study by Mary et al. [21] showed that FBLN5 blocked the interaction between fibronectin and integrins, thereby directly limiting the generation of reactive oxygen species driven by the ECM and promoting pancreatic cancer progression. This evidence concerns the gene FBLN5 and familial pancreatic carcinoma.